The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Name: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Address: Gyle Square, 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB
Contact Email: nss.hfsframeworkscotland@nhs.scot
Contact Telephone: +44 1312756511
Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.
Some PCS documents require login and recording interest on the source portal before download links are available.
No linked documents found for this notice.
External Link: https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR528295
Link Title: NP34925a Hepatitis B immunoglobulin intramuscular use (IM)
Link Description: Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.
Lot Description: The Framework Agreement is for the supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Lot 1 Status: complete
Lot 1 Has Options: No
Document Title: NP34925a Hepatitis B immunoglobulin intramuscular use (IM)
Document Description: Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.
{
"awards": [
{
"id": "ocds-r6ebe6-0000796275-1",
"relatedLots": [
"1"
],
"suppliers": [
{
"id": "org-27",
"name": "Bio Products Laboratory"
}
]
}
],
"buyer": {
"id": "org-8",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contracts": [
{
"awardID": "ocds-r6ebe6-0000796275-1",
"dateSigned": "2025-04-14T00:00:00Z",
"id": "ocds-r6ebe6-0000796275-1",
"status": "active",
"value": {
"amount": 343908.0,
"currency": "GBP"
}
}
],
"date": "2025-04-14T00:00:00Z",
"description": "The estimated value of the Framework Agreement referred to in Section V.2.4 covers the twenty-four (24) month contract duration and the twenty-four (24) month extension period of the Framework Agreement.\r\n (SC Ref:796275)",
"id": "rls-13-APR528295",
"initiationType": "tender",
"language": "EN",
"links": [
{
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000796275",
"rel": "canonical"
}
],
"ocid": "ocds-r6ebe6-0000796275",
"parties": [
{
"address": {
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM",
"streetAddress": "Gyle Square, 1 South Gyle Crescent"
},
"contactPoint": {
"email": "nss.hfsframeworkscotland@nhs.scot",
"telephone": "+44 1312756511",
"url": "http://"
},
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://www.hfs.scot.nhs.uk"
},
"id": "org-8",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer"
]
},
{
"address": {
"locality": "Hertfordshire",
"postalCode": "WD6 3BX",
"region": "UK",
"streetAddress": "Dagger Lane, Elstree"
},
"contactPoint": {},
"details": {
"scale": "large",
"url": "http://"
},
"id": "org-27",
"identifier": {
"legalName": "Bio Products Laboratory"
},
"name": "Bio Products Laboratory",
"roles": [
"supplier"
]
},
{
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"streetAddress": "27 Chambers Street"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525",
"url": "http://"
},
"id": "org-26",
"identifier": {
"legalName": "Sheriff Court House"
},
"name": "Sheriff Court House",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"id": "33600000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.",
"documents": [
{
"description": "Supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland.",
"documentType": "awardNotice",
"format": "text/html",
"id": "APR528295",
"title": "NP34925a Hepatitis B immunoglobulin intramuscular use (IM)",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=APR528295"
}
],
"id": "ocds-r6ebe6-0000796275",
"items": [
{
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "The Scottish National Blood Transfusion Service, Edinburgh (SNBTS).\r\n OR\r\n Upon request: designated delivery points throughout Scotland for use by Participating Authorities."
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"description": "The Framework Agreement is for the supply of Hepatitis B immunoglobulin intramuscular use (IM) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.",
"hasOptions": false,
"id": "1",
"status": "complete"
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "Although Hepatitis B immunoglobulin intramuscular use (IM) has lost patent protection there is no known generic competition in the UK marketplace due to the difficulties in replicating the manufacturing process, in line with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.",
"procurementMethodRationaleClassifications": [
{
"description": "The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons",
"id": "D_TECHNICAL",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"reviewDetails": "The notification will incorporate a \u00e2\u0080\u0098standstill period\u00e2\u0080\u0099 of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority proposes to conclude the relevant framework agreement.\r\n The bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer.\r\n The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NP34925a Hepatitis B immunoglobulin intramuscular use (IM)"
}
}